Want to see IN:INDIAGLYCO full AI Analyst Report?
India Glycols Limited (INDIAGLYCO) AI Stock Analysis
Top Page
India Glycols Limited
(NSE:INDIAGLYCO)
Overall score is driven by attractive valuation (low P/E) and positive technical trend (price above major moving averages). These strengths are tempered by financial performance risk, primarily persistent negative free cash flow and weak cash conversion, alongside notable gross margin compression.
India Glycols Limited (INDIAGLYCO) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 20.77B
- Dividend Yield
- 0.78%
- Average Volume (3M)
- 88.35K
- Price to Earnings (P/E)
- 6.7
- Beta (1Y)
- 1.58
- Revenue Growth
- 12.01%
- EPS Growth
- 23.71%
- Country
- India
- Employees
- 1,409
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals
India Glycols Limited Business Overview & Revenue Model
Company Description
India Glycols Limited, a green petrochemical company, manufactures and sells industrial chemicals in India. It operates through Bio-based Specialities and Performance Chemicals, Potable Spirits, and Ennature Biopharma segments. The company offers bio...
How the Company Makes Money
India Glycols Limited primarily makes money by manufacturing and selling chemicals to domestic and export customers. Its revenue model is product-sales driven, with earnings generated from (a) bulk/industrial chemicals and (b) higher-value specialty...
India Glycols Limited Financial Statement Overview
Summary
Strong multi-year revenue growth and generally healthy profitability are offset by meaningful gross margin compression (from ~41% in FY2023 to ~20% in FY2026) and weak earnings quality: free cash flow remains negative (about -1.7B) despite improved operating cash flow, indicating persistent cash burn after capex.
Income Statement
72PositiveBalance Sheet
66PositiveCash Flow
38Negative| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 43.01B | 42.11B | 37.68B | 32.94B | 26.37B | 28.68B |
| Gross Profit | 12.61B | 8.61B | 9.99B | 10.55B | 10.69B | 8.45B |
| EBITDA | 6.86B | 7.00B | 5.11B | 4.28B | 3.48B | 4.98B |
| Net Income | 3.16B | 2.93B | 2.31B | 1.73B | 1.25B | 3.40B |
Balance Sheet | ||||||
| Total Assets | 0 | 65.23B | 61.76B | 56.17B | 48.58B | 46.31B |
| Cash, Cash Equivalents and Short-Term Investments | 318.66M | 889.30M | 546.92M | 746.42M | 2.83B | 430.66M |
| Total Debt | 0 | 16.91B | 18.92B | 13.48B | 11.12B | 10.42B |
| Total Liabilities | -29.33B | 35.90B | 39.20B | 35.66B | 29.57B | 28.58B |
| Stockholders Equity | 29.33B | 29.33B | 22.56B | 20.51B | 19.01B | 17.92B |
Cash Flow | ||||||
| Free Cash Flow | -650.60M | -1.73B | -3.98B | -1.14B | -1.13B | -2.64B |
| Operating Cash Flow | 1.06B | 6.51B | 3.62B | 4.39B | 3.26B | 1.16B |
| Investing Cash Flow | -1.59B | -8.17B | -7.36B | -5.03B | -3.30B | 764.47M |
| Financing Cash Flow | 637.20M | 1.91B | 3.54B | 899.12M | -5.10M | -1.89B |
India Glycols Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:INDIAGLYCO, the sentiment is Positive. The current price of 331.05 is above the 20-day moving average (MA) of 324.59, above the 50-day MA of 289.61, and above the 200-day MA of 224.40, indicating a bullish trend. The MACD of 8.30 indicates Positive momentum. The RSI at 56.01 is Neutral, neither overbought nor oversold. The STOCH value of 74.79 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:INDIAGLYCO.
India Glycols Limited Peers Comparison
Overall Rating
IN:GULPOLY77Outperform
IN:INDIAGLYCO67Neutral
IN:NAVINFLUOR59Neutral
IN:DEEPAKNTR55Neutral
IN:FLUOROCHEM52Neutral
IN:GODAVARIB44Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 77Outperform | INR 8.89B | 6.00 | ― | 1.05% | 9.30% | 425.35% | |
| 67Neutral | INR 22.19B | 6.71 | ― | 0.78% | 12.01% | 23.71% | |
| 59Neutral | INR 445.17B | 56.30 | ― | 0.17% | 45.68% | 100.24% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 55Neutral | INR 207.25B | 19.51 | ― | 0.49% | 25.13% | 99.89% | |
| 52Neutral | INR 466.94B | 76.35 | ― | 0.07% | 9.52% | -1.13% | |
| 44Neutral | INR 10.42B | 6797.00 | ― | ― | 7.00% | ― |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:INDIAGLYCO | India Glycols Limited | 331.05 | 123.45 | 59.47% | |
| IN:DEEPAKNTR | Deepak Nitrite Limited | 1519.50 | -208.95 | -12.09% | |
| IN:FLUOROCHEM | Gujarat Fluorochemicals Ltd. | 4250.70 | 533.31 | 14.35% | |
| IN:GODAVARIB | Godavari Biorefineries Limited | 203.55 | -64.80 | -24.15% | |
| IN:GULPOLY | Gulshan Polyols Limited | 142.50 | -12.49 | -8.06% | |
| IN:NAVINFLUOR | Navin Fluorine International Limited | 8676.35 | 2788.32 | 47.36% |
India Glycols Limited Corporate Events
India Glycols to Appeal GST Penalty Imposed by Uttarakhand Tax Authority
India Glycols Limited has disclosed that the State Tax Officer, SGST Department, Uttarakhand has imposed a GST-related penalty of Rs. 6,22,080 on the company. The penalty arises from an inspection of a goods vehicle where Part-B details in the e-way...
India Glycols shifts upcoming investor meetings to virtual format
India Glycols Limited has notified stock exchanges that its upcoming analyst and institutional investor meetings, previously planned as in-person interactions, will now be conducted virtually on 7 and 8 October 2026. The company emphasized that all o...
India Glycols issues cost apportionment guidance after bio pharma and spirits demerger
India Glycols Limited has completed a demerger under a court-approved scheme, transferring its Bio Pharma and Spirits & Biofuel undertakings into Ennature Bio Pharma Limited and IGL Spirits Limited, respectively. As part of this restructuring, sh...
India Glycols Schedules Analyst and Institutional Investor Meeting in Mumbai
India Glycols Limited has scheduled a physical group meeting with analysts and institutional investors in Mumbai on Wednesday, 2 September 2026, starting at 5:00 p.m. IST. The company has cautioned that the schedule may change due to exigencies invol...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 28, 2026